These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12557137)

  • 1. Hepatitis C, iron status, and disease severity: relationship with HFE mutations.
    Tung BY; Emond MJ; Bronner MP; Raaka SD; Cotler SJ; Kowdley KV
    Gastroenterology; 2003 Feb; 124(2):318-26. PubMed ID: 12557137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L; Fracanzani AL; Bugianesi E; Dongiovanni P; Galmozzi E; Vanni E; Canavesi E; Lattuada E; Roviaro G; Marchesini G; Fargion S
    Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
    Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
    Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.
    Bonkovsky HL; Naishadham D; Lambrecht RW; Chung RT; Hoefs JC; Nash SR; Rogers TE; Banner BF; Sterling RK; Donovan JA; Fontana RJ; Di Bisceglie AM; Ghany MG; Morishima C;
    Gastroenterology; 2006 Nov; 131(5):1440-51. PubMed ID: 17101320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C.
    Geier A; Reugels M; Weiskirchen R; Wasmuth HE; Dietrich CG; Siewert E; Gartung C; Lorenzen J; Bosserhoff AK; Brügmann M; Gressner AM; Matern S; Lammert F
    Liver Int; 2004 Aug; 24(4):285-94. PubMed ID: 15287851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.
    Valenti L; Pulixi EA; Arosio P; Cremonesi L; Biasiotto G; Dongiovanni P; Maggioni M; Fargion S; Fracanzani AL
    Haematologica; 2007 Aug; 92(8):1037-42. PubMed ID: 17640859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C.
    Bonkovsky HL; Troy N; McNeal K; Banner BF; Sharma A; Obando J; Mehta S; Koff RS; Liu Q; Hsieh CC
    J Hepatol; 2002 Dec; 37(6):848-54. PubMed ID: 12445428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of hemochromatosis genes in chronic hepatitis C.
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R; Baldassarre R
    Clin Ter; 2006; 157(1):61-8. PubMed ID: 16669553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic iron, serum ferritin, HFE mutation, and hepatic fibrosis in chronic hepatitis C.
    Won JE; Jeong SH; Chung JI; Lee JH; Hwang SH; Kim JW; Lee SH; Kim N; Park YS; Lee DH; Kim H
    Intervirology; 2009; 52(5):239-46. PubMed ID: 19602897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HFE gene mutations, hepatic iron content, and histological severity in hepatitis C virus-induced chronic hepatitis.
    Ladero JM; Ropero P; Ortega L; Taxonera C; González FA; López-Alonso G; Briceño O; Rodríguez-Agulló JL; González L; Villegas A; Díaz-Rubio M
    Rev Esp Enferm Dig; 2003 Dec; 95(12):829-36. PubMed ID: 14972004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The H63D genetic variant of the HFE gene is independently associated with the virological response to interferon and ribavirin therapy in chronic hepatitis C.
    Carneiro MV; Souza FF; Teixeira AC; Figueiredo JF; Villanova MG; Secaf M; Passos AD; Ramalho LN; Carneiro FP; Zucoloto S; Candolo Martinelli AL
    Eur J Gastroenterol Hepatol; 2010 Oct; 22(10):1204-10. PubMed ID: 20555268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron, the HFE gene, and hepatitis C.
    Eisenbach C; Gehrke SG; Stremmel W
    Clin Liver Dis; 2004 Nov; 8(4):775-85, vii-viii. PubMed ID: 15464655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis.
    Erhardt A; Maschner-Olberg A; Mellenthin C; Kappert G; Adams O; Donner A; Willers R; Niederau C; Häussinger D
    J Hepatol; 2003 Mar; 38(3):335-42. PubMed ID: 12586300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
    Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
    Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron overload and HFE gene mutations in Czech patients with chronic liver diseases.
    Dostalikova-Cimburova M; Kratka K; Stransky J; Putova I; Cieslarova B; Horak J
    Dis Markers; 2012; 32(1):65-72. PubMed ID: 22297603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are haemochromatosis mutations related to the severity of liver disease in hepatitis C virus infection?
    Martinelli AL; Franco RF; Villanova MG; Figueiredo JF; Secaf M; Tavella MH; Ramalho LN; Zucoloto S; Zago MA
    Acta Haematol; 2000; 102(3):152-6. PubMed ID: 10692680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype.
    Gehrke SG; Stremmel W; Mathes I; Riedel HD; Bents K; Kallinowski B
    J Mol Med (Berl); 2003 Dec; 81(12):780-7. PubMed ID: 14557859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of iron overload and HFE gene mutations in the era of pegylated interferon and ribavirin treatment of chronic hepatitis C.
    Sikorska K; Stalke P; Izycka-Swieszewska E; Romanowski T; Bielawski KP
    Med Sci Monit; 2010 Mar; 16(3):CR137-143. PubMed ID: 20190684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Iron as comorbid factor in chronic hepatitis C].
    Erhardt A; Hauck K; Häussinger D
    Med Klin (Munich); 2003 Dec; 98(12):685-91. PubMed ID: 14685669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
    Bugianesi E; Manzini P; D'Antico S; Vanni E; Longo F; Leone N; Massarenti P; Piga A; Marchesini G; Rizzetto M
    Hepatology; 2004 Jan; 39(1):179-87. PubMed ID: 14752836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.